Financial Statements

Amphastar Pharmaceuticals, Inc. (AMPH)


-0.02 (-0.06%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 1181166776-
Net Income 63149-65
Stock Dividends -1--0-372
Dividend Paid -----
Retained Earnings 1801181166776

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 281234210185-
Annual Depreciation -36816572220
Capital Expenditure --34-42-47-35
Net PPE 245281234210185

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -4444
New Purchases -6-0-9-14-
Intangible and Goodwill 4444-

Amphastar Pharmaceuticals, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Amphastar Pharmaceuticals, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.